Zeuzem, Stefan

Publishing since 1988 (Dinosaur)

Has published 334 publications in 23 years

Number of publications published per year by Zeuzem, Stefan. (Source : PubMed)

Distribution of publications types for Zeuzem, Stefan. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Albert JG, Vogl T, Zeuzem S, Bojunga J. Use of Computed Tomography with Reformatted Imaging to Identify Ingested Drug Packets.  Clin. Gastroenterol. Hepatol.  2010  
•  Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U, Schmidt HH, Spengler U, Wirth S, Kessler HH, Peck-Radosavljevic M, Ferenci P, Vogel W, Moradpour D, Heim M, Cornberg M, Protzer U, Manns MP, Fleig WE, Dollinger MM, Zeuzem S. [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]  Z Gastroenterol  2010;48;2  
•  Sarrazin C, Zeuzem S. Resistance to direct antiviral agents in patients with hepatitis C virus infection.  Gastroenterology  2010;138;2  
•  Diago M, Shiffman ML, Bronowicki JP, Zeuzem S, Rodriguez-Torres M, Pappas SC, Tietz A, Nelson DR. Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin.  Hepatology  2010  
•  Friedrich-Rust M, Müller C, Winckler A, Kriener S, Herrmann E, Holtmeier J, Poynard T, Vogl TJ, Zeuzem S, Hammerstingl R, Sarrazin C. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.  J. Clin. Gastroenterol.  2010;44;1  
•  Zeuzem S. Do differences in pegylation of interferon alfa matter?  Gastroenterology  2010;138;1  
•  Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U. Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C.  J. Viral Hepat.  2010;17;1  
•  Askarieh G, Alsiö A, Pugnale P, Negro F, Ferrari C, Neumann AU, Pawlotsky JM, Schalm SW, Zeuzem S, Norkrans G, Westin J, Söderholm J, Hellstrand K, Lagging M. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C.  Hepatology  2009  
•  Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem S, Steyerberg EW, Janssen HL. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.  Gastroenterology  2009;137;6  
•  Lange CM, Bojunga J, Hofmann WP, Wunder K, Mihm U, Zeuzem S, Sarrazin C. Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function.  Hepatology  2009;50;6  

[ See timeline ] [ See all publications ]